UK Markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
7.600.00 (0.00%)
At close: 12:43PM BST

BRAIN Biotech AG

Darmstädter Strasse 34-36
Zwingenberg 64673
49 62 51 9331 0

Full-time employees299

Key executives

NameTitlePayExercisedYear born
Mr. Adriaan MoelkerChairman of the Management Board & CEO620kN/AN/A
Mr. Lukas LinnigCFO & Member of Management Board315kN/A1993
Mr. Ulrich PutschCo-FounderN/AN/AN/A
Michael SchneidersHead of Investor Relations & SustainabilityN/AN/AN/A
Dr. Ute DechertVP of HR & ProcessesN/AN/A1961
Dr. Jurgen EckConsultantN/AN/A1962
Dr. Martin LangerExec. VP & Head of Bus. Devel.N/AN/A1965
Dr. Michael KrohnExec. VP and Head of R&DN/AN/A1963
Thomas DeichmannHead of PRN/AN/AN/A
Dr. Michael WaidelichHead of Skin Care Bus. UnitN/AN/A1975
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and nature-based active ingredients for product development in the food, animal feed, skin care, cosmetics, and chemical industries. The company also identifies and develops optimized enzymes and biocatalysts for the production of food and beverages, and wound care preparations or lubricants, as well as for starch processing of bioethanol production; and microorganisms as the functional biomass for optimized industrial production processes, recycling of greenhouse gas CO2 as an industrial raw material, and extraction of precious and rare earth metals. It has strategic partnerships with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Corporate governance

BRAIN Biotech AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.